The Office of the Commissioner of Baseball announced late Thursday that two Minor League players from the Chicago Cubs organization, pitcher Ericdervid Martinez and outfielder Gregorio Robles, have received 50-game suspensions after each tested positive for a performance-enhancing substance in violation of the Minor League Drug Prevention and Treatment Program. Martinez tested positive for metabolites of Stanozolol, while Robles tested positive for metabolites of Boldenone and Clomiphene.
The suspensions of both players, who are members of the organizationās Dominican Summer League team, are effective immediately.
(See the complete history of drug suspensions in major and minor league baseball)
With the addition of the two Cubs players, drug suspensions as part of the Minor League Drug Prevention and Treatment Program totals an even 50. At the point of yesterdayās suspension there were a total of 30 suspensions over the same period last season.
Martinezā suspension for Clomiphene could possibly be a first. Players suspended under MLBās drug policy are only announced as āPEDsā while minor league suspensions announce the violating substance. Clomiphene has never been associated to any of the minor league drug suspensions to date. Clomiphene is used as a ākick starterā which implies that Martinez was tested just after a steroid (Boldenone) cycle.
Maury Brown is the Founder and President of the Business of Sports Network, which includes The Biz of Baseball, The Biz of Football, The Biz of Basketball and The Biz of Hockey. He is contributor to Baseball Prospectus, and is available as a freelance writer. Brown's full bio is here. He looks forward to your comments via email and can be contacted through the Business of Sports Network (select his name in the dropdown provided).
Don't forget to register and log in on The Biz of Baseball site to get updates via your in-box, and see information only logged in members can see.
Follow Maury Brown on Twitter
Follow The Biz of Baseball on Twitter